Clinical Trial Update: Phase 2 Study of TAK-850 in Comparison With Influenza Hemagglutinin (HA) Vaccine in Healthy Adult Participants [Phase 2]

View source ↗

Summary

TAK-850 was studied in a Phase 2 trial comparing it with the standard influenza HA vaccine in healthy adults, with results posted on 2016-12-29. The study evalu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Influenza Infection

Drugs mentioned

• TAK-850

Snippet

Sponsor: Takeda | Conditions: Influenza Infection | Phase 2 | Status: COMPLETED | Results posted: 2016-12-29